141 related articles for article (PubMed ID: 12472496)
1. Cosmetic color improvement of the nipple-areola complex by optimal use of tretinoin and hydroquinone.
Yoshimura K; Momosawa A; Watanabe A; Sato K; Matsumoto D; Aiba E; Harii K; Yamamoto T; Aoyama T; Iga T
Dermatol Surg; 2002 Dec; 28(12):1153-7; discussion 1158. PubMed ID: 12472496
[TBL] [Abstract][Full Text] [Related]
2. A new bleaching protocol for hyperpigmented skin lesions with a high concentration of all-trans retinoic acid aqueous gel.
Yoshimura K; Harii K; Aoyama T; Shibuya F; Iga T
Aesthetic Plast Surg; 1999; 23(4):285-91. PubMed ID: 10441721
[TBL] [Abstract][Full Text] [Related]
3. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals.
Yoshimura K; Harii K; Aoyama T; Iga T
Plast Reconstr Surg; 2000 Mar; 105(3):1097-108; discussion 1109-10. PubMed ID: 10724272
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial of bleaching treatment with 10% all-trans retinol gel.
Yoshimura K; Momosawa A; Aiba E; Sato K; Matsumoto D; Mitoma Y; Harii K; Aoyama T; Iga T
Dermatol Surg; 2003 Feb; 29(2):155-60; discussion 160. PubMed ID: 12562345
[TBL] [Abstract][Full Text] [Related]
5. Nevoid hyperkeratosis of the nipple and areola: treatment with topical retinoic acid.
Okan G; Baykal C
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):218-20. PubMed ID: 10642060
[TBL] [Abstract][Full Text] [Related]
6. Nevoid hyperkeratosis of the areola.
Marín-Bertolín S; González-Martínez R; Marquina Vila P
Plast Reconstr Surg; 1998 Jul; 102(1):275-6. PubMed ID: 9655458
[No Abstract] [Full Text] [Related]
7. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.
Woodhall KE; Goldman MP; Gold MH; Biron J
J Drugs Dermatol; 2009 Sep; 8(9):862-7. PubMed ID: 19746679
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for acquired dermal melanocytosis.
Momosawa A; Yoshimura K; Uchida G; Sato K; Aiba E; Matsumoto D; Yamaoka H; Mihara S; Tsukamoto K; Harii K; Aoyama T; Iga T
Dermatol Surg; 2003 Oct; 29(10):1001-7. PubMed ID: 12974695
[TBL] [Abstract][Full Text] [Related]
9. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of topical bleaching treatment with nanoscale tretinoin particles and hydroquinone for hyperpigmented skin lesions.
Sato K; Matsumoto D; Iizuka F; Aiba-Kojima E; Machino C; Suga H; Watanabe-Ono A; Inoue K; Gonda K; Yoshimura K
Dermatol Surg; 2007 Aug; 33(8):937-44. PubMed ID: 17661936
[TBL] [Abstract][Full Text] [Related]
11. A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
Draelos ZD; Raab S; Yatskayer M; Chen N; Krol Y; Oresajo C
J Drugs Dermatol; 2015 Apr; 14(4):386-90. PubMed ID: 25844613
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment.
Yoshimura K; Harii K; Masuda Y; Takahashi M; Aoyama T; Iga T
Aesthetic Plast Surg; 2001; 25(2):129-33. PubMed ID: 11349303
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
Nanda S; Grover C; Reddy BS
Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
[TBL] [Abstract][Full Text] [Related]
15. Hyperkeratosis of the nipple: report of two cases.
Alpsoy E; Yilmaz E; Aykol A
J Dermatol; 1997 Jan; 24(1):43-5. PubMed ID: 9046740
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians.
Momosawa A; Kurita M; Ozaki M; Miyamoto S; Kobayashi Y; Ban I; Harii K
Plast Reconstr Surg; 2008 Jan; 121(1):282-288. PubMed ID: 18176232
[TBL] [Abstract][Full Text] [Related]
17. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing.
West TB; Alster TS
Dermatol Surg; 1999 Jan; 25(1):15-7. PubMed ID: 9935086
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark-Skinned Patients: A Comparative Study.
Sarkar R; Parmar NV; Kapoor S
Dermatol Surg; 2017 Apr; 43(4):566-573. PubMed ID: 28114204
[TBL] [Abstract][Full Text] [Related]
19. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies.
Fleischer AB; Schwartzel EH; Colby SI; Altman DJ
J Am Acad Dermatol; 2000 Mar; 42(3):459-67. PubMed ID: 10688717
[TBL] [Abstract][Full Text] [Related]
20. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A.
Schlessinger J; Kenkel J; Werschler P
Aesthet Surg J; 2011 Jul; 31(5):529-39. PubMed ID: 21719866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
